LONDON — The German biotechnology company CureVac says it has withdrawn its application for the approval of its coronavirus vaccine from the European Medicines Agency and will focus on making next-generation messenger RNA vaccines.
In a statement on Tuesday, CureVac says recent communications with the EU drug regulator suggested its COVID-19 vaccine might only be authorized in mid-2022. Earlier this year, the company described its initial vaccine results as “sobering,” after data suggested the shot was only about 47% effective.
CureVac says it will instead prioritize the development of second-generation mRNA vaccines with its partner GlaxoSmithKline and expects to be in “late-stage clinical development” by the middle of next year.
The EMA confirmed Tuesday it had ended the accelerated evaluation of the CureVac vaccine, a process started in February. COVAX, the U.N.-backed effort to share vaccines globally, had been waiting for possible doses from CureVac, which received funding from one of the COVAX partners.
BEIJING (AP) — Genetic material collected at a Chinese market near where the first human cases of COVID-19 were identified show raccoon dog DNA comingled with the virus, adding evidence to the theory that the virus originated from animals, not from a lab, international experts say.
FALMOUTH, MA – The police in Falmouth have identified the victim in an accident involving a car plunging into the ocean on February 20, NBC10 Boston reported.
NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.
Explore articles from the past and connect to your heritage!
Discover the benefits of a subscription including access to exclusive content, events, and more!
Have an idea for a story, or know of an event we should cover? We want to hear about it!
The National Herald is the paper of record of the Greek Diaspora community. Through independent journalism, we bring news to generations of Greek-Americans, with stories on the individual, community and international level. Visit and support our 106 year-old sister publication Εθνικός Κήρυξ.
To purchase a gift subscription, please log out of your account, and purchase the subscription with a new email ID.
Sign up to receive our daily email news briefing.
Sign up for a subscription to The National Herald,
starting as low as $1/week.
and receive more access to The National Herald
View our Terms of Service + Privacy Policy.
and receive more access to The National Herald
View our Terms of Service + Privacy Policy.
We use cookies on our site to personalize your experience, bring you the most relevant content, show you the most useful ads, and to help report any issues with our site. You can update your preferences at any time by visiting preferences. By selecting Accept, you consent to our use of cookies. To learn more about how your data is used, visit our cookie policy.
$1.08 USD
